Case Background:
This is a federal securities fraud class action lawsuit on behalf of those who purchased or otherwise acquired Acadia Healthcare Company (“Acadia”) (NASDAQ: ACHC) securities between April 30, 2014 and November 15, 2018, inclusive (the “Class Period”).
The complaint alleges that, throughout and before the Class Period, Defendants made numerous materially false and misleading statements and omissions to investors regarding Acadia’s business and operations, including by falsely stating that the quality of its U.K. operations gave the company a “competitive strength,” which would drive future growth and profitability, and by issuing false and misleading guidance regarding the company’s actual and projected 2017 revenue, earnings before interest, taxes, depreciation and amortization and earnings per share.
Current Status of Case:
On September 30, 2022, the Court granted Lead Plaintiffs’ Motion for Class Certification. This action set for trial to begin on November 18, 2025, and is ongoing.
If you wish to discuss this action or have any questions, please contact Kessler Topaz Meltzer & Check, LLP: Jon Naji, Esq. (484) 270-1453; toll-free at (844) 887-9500; or via e-mail at info@ktmc.com. If you would like additional information about the suit, please click on the link "Submit Your Information" above and fill out the form as promptly as possible.